These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 4695953

  • 1. Immunochemical and biologic characterization of alloantibody active in immunologic enhancement.
    Fuller TC, Winn HJ.
    Transplant Proc; 1973 Mar; 5(1):585-7. PubMed ID: 4695953
    [No Abstract] [Full Text] [Related]

  • 2. Immunologic enhancement induced by antibody fragments.
    Cruse JM, Forbes JT, Gillespie GY, Lewis GK.
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Mar; 140(3):259-67. PubMed ID: 4251393
    [No Abstract] [Full Text] [Related]

  • 3. Immunologic enhancement induced by 7S antibody globulin.
    Cruse JM, Azar MM.
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Mar; 132(3):240-6. PubMed ID: 4232737
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunologic enhancement in a syngeneic tumor system.
    Beltz WR, Levy NL.
    Surg Forum; 1975 Mar; 26():142-4. PubMed ID: 1216091
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Demonstration and identification of cytotoxic antibodies and antibodies blocking the cell-mediated antitumor immunity against adenovirus type 12-induced tumors.
    Ankerst J.
    Cancer Res; 1971 Jul; 31(7):997-1003. PubMed ID: 4327089
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [On the antibody production in dysgammaglobulinaemic hens. I. Isohaemagglutinins].
    Brüggemann J, Friedrich B, Lösch U, Schmid DO.
    Z Immunitatsforsch Exp Klin Immunol; 1971 Jul; 141(3):280-9. PubMed ID: 4251870
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lymphocyte-antibody interactions in immunological enhancement.
    Takasugi M, Hildemann WH.
    Transplant Proc; 1969 Mar; 1(1):530-4. PubMed ID: 5406837
    [No Abstract] [Full Text] [Related]

  • 14. Specificity of immune paralysis at large tumor volumes.
    Pardridge DH, Wang BS, Mannick JA, Deckers PJ.
    Surg Forum; 1975 Mar; 26():118-20. PubMed ID: 56046
    [No Abstract] [Full Text] [Related]

  • 15. Antigen driven selection for Fc receptors of enhancing antibody on macrophages during an alloimmune response.
    Whitten HD, Cruse JM, Lewis GK, Watson ES.
    J Reticuloendothel Soc; 1974 Feb; 15(2):118-25. PubMed ID: 4815211
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantitative studies on tumor enhancement in mice. I. Enhancement of sarcoma I induced by IgM, IgG1, and IgG2.
    Rubinstein P, Decary F, Streun EW.
    J Exp Med; 1974 Aug 01; 140(2):591-6. PubMed ID: 4846488
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Immunological interactions in tumor growth].
    Saal F, Colmerauer ME, Rumi L, Pasqualini CD.
    Sangre (Barc); 1973 Aug 01; 18(1):9-14. PubMed ID: 4708557
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.